Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palombi

Showing results (551-560 of 563) with videos related to

Pageof 57
Sort By:
International Journal of Molecular Sciences|March 22, 2019
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?Francesco Marchesi, Fulvia Pimpinelli, Enea Gino Di Domenico, et al.
The Breast Journal|December 24, 2025
Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian StudyMaria Agnese Fabbri, Alberto Fulvi, Matteo Vergati, et al.
Translational Medicine @ Unisa|November 30, 2016
The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older AdultsG Liotta, F Orfila, M Vollenbroek-Hutten, et al.
Annals of Hematology|July 30, 2021
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana LinfomiArmando Santoro, Rita Mazza, Michele Spina, et al.
International Journal of Environmental Research and Public Health|October 28, 2015
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelGiuseppe Liotta, Maria Cristina Marazzi, Khethimipilo E Mothibi, et al.
British Journal of Haematology|November 9, 2018
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 studyEmilio Iannitto, Monica Bellei, Sandy Amorim, et al.
Hematological Oncology|January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient JourneyLisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
Advances in Nutrition (Bethesda, Md.)|September 17, 2017
Perspective: Essential Study Quality Descriptors for Data from Nutritional Epidemiologic ResearchChen Yang, Mariona Pinart, Patrick Kolsteren, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Haematologica|June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Pageof 57

Showing results (551-560 of 563) with videos related to

Sort By:
Pageof 57
International Journal of Molecular Sciences|March 22, 2019
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?Francesco Marchesi, Fulvia Pimpinelli, Enea Gino Di Domenico, et al.
The Breast Journal|December 24, 2025
Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian StudyMaria Agnese Fabbri, Alberto Fulvi, Matteo Vergati, et al.
Translational Medicine @ Unisa|November 30, 2016
The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older AdultsG Liotta, F Orfila, M Vollenbroek-Hutten, et al.
Annals of Hematology|July 30, 2021
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana LinfomiArmando Santoro, Rita Mazza, Michele Spina, et al.
International Journal of Environmental Research and Public Health|October 28, 2015
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelGiuseppe Liotta, Maria Cristina Marazzi, Khethimipilo E Mothibi, et al.
British Journal of Haematology|November 9, 2018
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 studyEmilio Iannitto, Monica Bellei, Sandy Amorim, et al.
Hematological Oncology|January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient JourneyLisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
Advances in Nutrition (Bethesda, Md.)|September 17, 2017
Perspective: Essential Study Quality Descriptors for Data from Nutritional Epidemiologic ResearchChen Yang, Mariona Pinart, Patrick Kolsteren, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Haematologica|June 26, 2025
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, et al.
Pageof 57